Cargando…
Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance
Multidrug resistance (MDR) is one of the major barriers in chemotherapy. It is often related to the overexpression of efflux receptors such as P-glycoprotein (P-gp). Overexpressed efflux receptors inhibit chemotherapeutic efficacy by pumping out intracellularly delivered anticancer drugs. In P-gp-me...
Autores principales: | Han, Eunkyung, Kim, Doyeon, Cho, Youngheun, Lee, Seonock, Kim, Jungho, Kim, Hyuncheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920864/ https://www.ncbi.nlm.nih.gov/pubmed/36770754 http://dx.doi.org/10.3390/molecules28031087 |
Ejemplares similares
-
Development of a Polymersome-Based Nanomedicine for Chemotherapeutic and Sonodynamic Combination Therapy
por: Kim, Mingyun, et al.
Publicado: (2023) -
Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy
por: Li, Xin, et al.
Publicado: (2018) -
Redox-Responsive Polymersomes as Smart Doxorubicin Delivery Systems
por: Ferrero, Carmen, et al.
Publicado: (2022) -
Overcoming anticancer resistance by photodynamic therapy-related efflux pump deactivation and ultrasound-mediated improved drug delivery efficiency
por: Kim, Doyeon, et al.
Publicado: (2020) -
Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)